SYK STRYKER CORP

2026Q1 · CUSIP 863667101 · Sector: Healthcare & Biotech

Danger · Dual-confirm: breadth + price

Holders

2,288

Δ holders QoQ

-34

Breadth percentile

Top 96%

Whale holders

344

Δ whales

Inst. holding value

$93.2B

New positions

163

Closed positions

197

Price momentum (1Q)

-14.9%

Put / Call

27/26

Breadth history (34 quarters)

Past Lit Events & Aftermath 23 lit events

Period	Percentile	Next-1Q return	Next-2Q return
2025Q4	Top 9%	-14.9%	—
2025Q2	Top 8%	-4.9%	-0.7%
2025Q1	Top 7%	-1.0%	-8.4%
2024Q4	Top 2%	+2.6%	+1.6%
2024Q3	Top 5%	-1.5%	-2.4%
2024Q1	Top 1%	+2.1%	+17.1%
2023Q4	Top 3%	-4.0%	-1.9%
2023Q2	Top 1%	+0.8%	+24.5%
2023Q1	Top 1%	-1.9%	+0.4%
2022Q4	Top 1%	+8.7%	+6.1%
2022Q1	Top 8%	-7.1%	-6.5%
2021Q4	Top 4%	-10.3%	-14.4%
2021Q2	Top 6%	-0.0%	-5.0%
2021Q1	Top 17%	+5.5%	+5.5%
2020Q4	Top 4%	+1.9%	+7.5%
2020Q2	Top 6%	+23.0%	+31.1%
2019Q4	Top 3%	-13.2%	-14.2%
2019Q3	Top 5%	+9.8%	-6.3%
2019Q1	Top 4%	+18.1%	+10.9%
2018Q4	Top 4%	-0.7%	+18.1%
2018Q3	Top 7%	+9.3%	+8.7%
2018Q2	Top 3%	-1.3%	+11.0%
2018Q1	Top 8%	-1.2%	-2.5%

Show all 23 events

Options Sentiment

Put holders

QoQ: -3

Call holders

QoQ: -1

See methodology →

Fundamentals

PE (TTM)

37.0

EPS (TTM)

$8.64

EPS YoY

+16.8%

Revenue (TTM)

$25.3B

Revenue YoY

+8.8%

Net margin

13.2%

ROE

14.5%

Debt ratio

50.4%

FCF (TTM)

$4.6B

Dividend (TTM)

$3.44

Quarterly Revenue & EPS (4Y)

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)

Get the next update

2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.